Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L -cysteine activation of Ca2+ -activated K+ (BK Ca ) channels in myocytes of the guinea-pig taenia caeca

Richard J Lang; John R Harvey; Emily L Mulholland

doi:10.1038/sj.bjp.0705349

Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L -cysteine activation of Ca2+ -activated K+ (BK Ca ) channels in myocytes of the guinea-pig taenia caeca

Richard J Lang, John R Harvey, Emily L Mulholland

Physiology

Research output: Contribution to journal › Article › Research › peer-review

28 Citations (Scopus)

Original language	English
Pages (from-to)	1153 - 1163
Number of pages	11
Journal	British Journal of Pharmacology
Volume	139
Issue number	6
DOIs	https://doi.org/10.1038/sj.bjp.0705349
Publication status	Published - 2003

Access to Document

10.1038/sj.bjp.0705349

Cite this

@article{a098c306027244e28ab1efeb512ba50d,

title = "Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L -cysteine activation of Ca2+ -activated K+ (BK Ca ) channels in myocytes of the guinea-pig taenia caeca",

author = "Lang, {Richard J} and Harvey, {John R} and Mulholland, {Emily L}",

year = "2003",

doi = "10.1038/sj.bjp.0705349",

language = "English",

volume = "139",

pages = "1153 -- 1163",

journal = "British Journal of Pharmacology",

issn = "1476-5381",

publisher = "Wiley-Blackwell",

number = "6",

}

Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L -cysteine activation of Ca2+ -activated K+ (BK Ca ) channels in myocytes of the guinea-pig taenia caeca. / Lang, Richard J; Harvey, John R; Mulholland, Emily L.

In: British Journal of Pharmacology, Vol. 139, No. 6, 2003, p. 1153 - 1163.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L -cysteine activation of Ca2+ -activated K+ (BK Ca ) channels in myocytes of the guinea-pig taenia caeca

AU - Lang, Richard J

AU - Harvey, John R

AU - Mulholland, Emily L

PY - 2003

Y1 - 2003

U2 - 10.1038/sj.bjp.0705349

DO - 10.1038/sj.bjp.0705349

M3 - Article

VL - 139

SP - 1153

EP - 1163

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 1476-5381

IS - 6

ER -